From rehabilitation to risk management: The goals of methadone programmes in Canada

International Journal of Drug Policy

Volumn 14, Issue 3, 2003, Pages 247-255

  Quirion, Bastien ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Canada; Drug use; Harm reduction; Methadone; Risk management

Indexed keywords

METHADONE;

ARTICLE; CANADA; COMMUNITY CARE; DRUG DEPENDENCE; DRUG PROGRAM; DRUG USE; HEALTH PROGRAM; HUMAN; POLITICS; PRIORITY JOURNAL; RISK MANAGEMENT; SOCIAL ASPECT; SOCIAL INTERACTION; WELFARE;

EID: 0042208309     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3959(03)00077-X     Document Type: Article

References (57)

1. Achim D., Lauzon P., Lehmann F. Le traitement de soutien par la méthadone chez le narcomane. Union Médicale du Canada. 110:1981;354-355.
2. Andersen G., Nutter R. Clients and outcomes of a methadone treatment programme. International Journal of the Addictions. 10(6):1975;937-948.
3. Arif, A., & Westermeyer, J. (1990). Methadone maintenance in the management of opioid dependance: An international review. New York: Praeger.
4. Bentley P. Canada's first drug treatment court. Criminal Reports. 31(2):2000;257-274.
5. Bishop J., Bennett J., DaSilva T., Foulks J., Halliday R., Holmes S. Methadone and the care of the narcotic addict: Report of a special joint committee of C.M.A. and the D.N.H.W. food and drug directorate. Canadian Medical Association Journal. 105:1971;1193-1201.
6. Brill, L. (1973). The international experience: A survey of maintenance programmes. In C. Chambers & L. Brill (Eds.), Methadone: Experiences and issues (pp. 327-346). New York: Behavioral Publications.
7. Castel, R. (1991). From dangerousness to risk. In C. Burchell, C. Gordon, & C. Miller (Eds.), The Foucault effect: Studies in governmentality (pp. 281-298). Chicago: University of Chicago Press.
8. Collège des médecins du Québec, Ordre des pharmaciens du Québec. (1999). Utilisation de la méthadone dans le traitement de la toxicomanie aux opiacés. Montréal: Collège des médecins du Québec, Service des affaires publiques et des communications.
9. Cox, C., & Smart, R. (1971). Preliminary report on the narcotics addiction unit methadone research: Pre-treatment data. Toronto: Addiction Research Foundation.
10. College of Physicians and Surgeons of British Columbia. (1971). A treatment programme for narcotic addicts. British Columbia Medical Journal, 13(4), 89-95.
11. Davey, J. D. (1995). The new social contract: America's journey from welfare state to police state. Westport, CT: Praeger.
12. Dole V., Nyswander M. Heroin addiction: A metabolic disease. Archives of Internal Medecine. 120:1967;19-24.
13. Editorial Board. (2001). Harm reduction: Closing the distance. Canadian Medical Association Journal, 165(4), 389.
14. Ferguson J., Ettinger G., Joron G., Laderman J., MacKenzie D. Good medical practice in the care of the narcotic addict. Canadian Medical Association Journal. 92:1965;1040-1043.
15. Fischer B. Prescription, power and politics: The turbulent history of methadone maintenance in Canada. Journal of Public Health Policy. 21(2):2000;187-210.
16. Fischer B., Gliksman L., Rehm J., Daniel N., Medved W. Comparing opiate users in methadone treatment with untreated opiate users: Results of a follow-up study with a Toronto opiate user cohort. Canadian Journal of Public Health. 90(5):1999;299-303.
17. Halliday R. Management of the narcotic addict. British Columbia Medical Journal. 5(10):1963;412-414.
18. Halliday, R. (1966). Narcotic drug addicts as voluntary patients: The use of methadone in short-term and long-term withdrawal treatment programme. Vancouver: Narcotic Addiction Foundation of British Columbia.
19. Health and Welfare Canada. (1990). Report of the advisory committee on the use of drugs in the treatment of abuse and dependence to narcotic and controlled drugs (Vol. 778, pp. 2-19). Information Letter of the Health Protection Branch.
20. Health and Welfare Canada. (1992). The use of opioids in the management of opioid dependence. Ottawa: Minister of Supply and Services Canada.
21. Health Canada. (2001a). Injection drug use and HIV/AIDS: Health Canada's response to the report of the Canadian HIV/AIDS legal network. Ottawa: Minister of Public Works and Government Services Canada.
22. Health Canada. (2001b). Reducing the harm associated with injection drug use in Canada. Ottawa: Minister of Public Works and Government Services Canada.
23. Hoffman M.B. The drug court scandal. North Carolina Law Review. 78:2000;1437-1534.
24. Holmes S. Treatment of narcotic addicts at the Foundation's Toronto Clinical Services. Addictions. 13(2):1966a;28-30.
25. Holmes, S. (1966b). A treatment approach to narcotic addiction. Toronto: Alcoholism and Drug Addiction Research Foundation.
26. Hughes, G. (1998). Understanding crime prevention: Social control, risk and late modernity. Buckingham: Open University Press.
27. Johnson S. Impact of institutional methadone maintenance treatment on release outcome. Forum on Corrections Research. 13(3):2001;51-53.
28. Johnson, S., van de Ven, J., & Grant, B. (2001). Institutional methadone maintenance treatment: Impact on release outcome and institutional behavior. Ottawa: Correctional Service of Canada, Addictions Research Centre.
29. Johnston, W., & Williams, H. (1970). Abstinence-relapse patterns among heroin addicts receiving methadone treatment on an outpatient basis. Proceedings from the third national conference on methadone treatment. New York: National Institute of Mental Health.
30. Krakowski M., Smart R. The outpatient treatment of heroin addicts with methadone. Canadian Journal of Public Health. 63:1972;397-404.
31. Krakowski M., Smart R. Social and psychological characteristics of heroin addicts dropping out of methadone treatment. Canadian Psychiatric Association Journal. 19:1974;41-47.
32. Latowsky M., Kallen E. Mainstreaming methadone maintenance treatment: The role of the family physician. Canadian Medical Association Journal. 157(4):1997;395-398.
33. Lauzon, P. (1988). Rapport final du projet pilote de maintenance à la méthadone. Montréal: Centre de recherche et d'aide pour narcomanes.
34. Lauzon P. Les modèles d'intervention avec méthadone développés au Québec, 1986-1996. Psychotropes. 4:1996;7-14.
35. LeDain, G. (1972). Report of the Commission of Inquiry into the non-medical use of Drugs: Treatment. Ottawa: Information Canada.
36. LeDain, G. (1973). Final report of the Commission of Inquiry into the non-medical use of Drugs. Ottawa: Information Canada.
37. MacKenzie R., Read J. Methadone maintenance programme. Alberta Medical Bulletin. 36(2):1971;49.
38. McKim, T. (1976). Trends in methadone use in the treatment of opiate dependence in Canada. Ottawa: Health and Welfare Canada.
39. Mugford S. Social change and the control of psychotropic drugs: Risk management, harm reduction and postmodernity. Drug and Alcohol Review. 12:1993;369-375.
40. Paulus I. A comparative study of long-term and short-term withdrawal of narcotic addicts voluntarily seeking comprehensive treatment. British Journal of Addiction. 63:1968;129-141.
41. Paulus I., Halliday R. Rehabilitation and the narcotic addict: Results of a comparative methadone withdrawal programme. Canadian Medical Association Journal. 96:1967;655-659.
42. Peachy, J. (1984). Report for the World Health Organization of methadone treatment in Canada. Toronto: Alcoholism and Drug Addiction Research Foundation.
43. Peachy J., Franklin T. Methadone treatment of opiate dependence in Canada. British Journal of Addiction. 80:1985;291-299.
44. Péladeau N., Fortin L., Lauzon P., Mercier C. Évolution d'hommes et de femmes dépendantes de l'héroïne avant et pendant le traitement de maintien à la méthadone. Psychotropes. 2(4):1996;24-43.
45. Perreault, M., Lauzon, P., Mercier, C., Rousseau, M., & Gagnon, C. (2001). Efficacité des programmemes comportant l'utilisation de la méthadone. In M. Landry, L. Guyon, & S. Brochu (Eds.), Impact du traitement en alcoolisme et toxicomanie: Études québécoises (pp. 95-135). Québec: Presses de l'Université Laval.
46. Quirion B. Reduction des méfaits et gestion des risques: Les frontières normatives entre les différents registres de régulation de la pratique psychotrope. Déviance et Société 26(4):2002;479-495.
47. Reichman N. Managing crime risks: Toward an insurance based model of social control. Research in Law, Deviance and Social Control. 8:1986;151-172.
48. Rosenbaum M. The demedicalization of methadone maintenance. Journal of Psychoactive Drugs. 27(2):1995;145-149.
49. Segal, R., Ali, W., & Parks, D. (1975). A follow-up study of patients in a methadone-based withdrawal programme. Toronto: Addiction Research Foundation.
50. Simon J. The emergence of a risk society: Insurance, law, and the state. Socialist Review. 95:1987;61-89.
51. Smart, R. (1983). Forbidden highs: The nature, treatment and prevention of illicit drug abuse. Toronto: Addiction Research Foundation.
52. Smart R., Everson A., Segal R., Finley J., Ballah B. A four-year follow-up study of narcotic-dependent persons receiving methadone maintenance substitution therapy. Canadian Journal of Public Health. 68:1977;55-58.
53. Stimson, G. V., & Oppenheimer, E. (1982). Heroin addiction: Treatment and control in Britain. London: Tavistock Publications.
54. Williams H. Treatment of the narcotic addict with some observations on other drug dependencies. British Columbia Medical Journal. 11(1):1969;11-13.
55. Williams H. Using methadone to treat the heroin addict. Canada's Mental Health. 18(2):1970a;4-9.
56. Williams H. Low and high methadone maintenance in the out-patient treatment of the hard core heroin addict. International Journal of the Addictions. 5(3):1970;439-447.
57. Williams H., Moy W., Johnston W. Low and high methadone maintenance in out-patient treatment of heroin addict. International Journal of the Addictions. 5(4):1970;637-644.